Neurology

Weekly Recap: 15 Health Press Releases You Need to SeeWeekly Recap: 15 Health Press Releases You Need to See

Weekly Recap: 15 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Google Cloud's commitment to AI-powered…

2 months ago
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual MeetingAlterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected…

2 months ago
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual MeetingTG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting…

2 months ago
Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic PainArialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain

Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain

HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes…

2 months ago
Glass House Brands Announces Hemp Research and Development Agreement with the University of California, BerkeleyGlass House Brands Announces Hemp Research and Development Agreement with the University of California, Berkeley

Glass House Brands Announces Hemp Research and Development Agreement with the University of California, Berkeley

LONG BEACH, Calif. and TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company")…

2 months ago
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ETANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that…

2 months ago
PhaseV to Present Transformative Use of AI for Clinical Development at Upcoming EventsPhaseV to Present Transformative Use of AI for Clinical Development at Upcoming Events

PhaseV to Present Transformative Use of AI for Clinical Development at Upcoming Events

Presentations to Highlight the Power of Advanced Machine Learning for Enhancing Trial Design, Execution and Analysis BOSTON, April 8, 2025…

2 months ago
Brainomix Advances Stroke Care with Landmark FDA ClearanceBrainomix Advances Stroke Care with Landmark FDA Clearance

Brainomix Advances Stroke Care with Landmark FDA Clearance

Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatmentsOXFORD, England…

2 months ago
Quibim Announces New Board of Directors To Promote Growth And Strategic ExpansionQuibim Announces New Board of Directors To Promote Growth And Strategic Expansion

Quibim Announces New Board of Directors To Promote Growth And Strategic Expansion

NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased…

2 months ago